Business Standard

Lupin Pharma launches Lurasidone Hydrochloride Tablets in US

The generic equivalent of Latuda tablets has been launched in the US markets

lupin
Premium

BS Web Team New Delhi
Lupin Limited, a global pharmaceutical company, has announced the launch of Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg, to market a generic equivalent of Latuda Tablets of Sunovion Pharmaceuticals, Inc. Lupin filed this update with the Bombay Stock Exchange. It issued a press release informing the public of the same.

The generic equivalent of Latuda tablets has been launched in the US markets. Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg (RLD Latuda) had estimated annual sales of $4.2 billion in the US, according

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 21 2023 | 2:36 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com